BC
LH icon

Bridgefront Capital’s Labcorp LH Stock Holding History

Bridgefront Capital’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,670
Closed -$479K – 673
2025
Q3 		$479K Buy
+1,670
New +$447K 0.14% 258
2024
Q3 		– Sell
-1,107
Closed -$225K – 641
2024
Q2 		$225K Sell
1,107
-3,581
-76% -$728K 0.09% 380
2024
Q1 		$1.02M Buy
+4,688
New +$1.03M 0.78% 6
2023
Q3 		– Sell
-3,137
Closed -$650K – 513
2023
Q2 		$650K Buy
3,137
+572
+22% +$111K 0.35% 71
2023
Q1 		$506K Buy
+2,565
New +$528K 0.31% 102
2022
Q2 		– Sell
-1,256
Closed -$284K – 385
2022
Q1 		$284K Buy
1,256
+248
+25% +$58.3K 0.35% 120
2021
Q4 		$272K Buy
+1,008
New +$250K 0.26% 166
2021
Q1 		– Sell
-3,935
Closed -$688K – 811
2020
Q4 		$688K Buy
+3,935
New +$680K 0.24% 126

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bridgefront Capital's LH Position: Q4 2025 in Review

Bridgefront Capital sold out of Labcorp (LH) in Q4 2025, closing a stake of 1,670 shares — an estimated $479K sold.

Bridgefront Capital first reported a position in LH in Q4 2020 and held it in 8 quarters. The position peaked at $1.02M in Q1 2024. 1,024 funds tracked by Wall St. Rank hold LH as of Q4 2025.

  • Bridgefront Capital reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
  • Bridgefront Capital sold 1,670 Labcorp shares in Q4 2025, an estimated $479K.
  • Bridgefront Capital first reported a position in Labcorp in Q4 2020 and held it in 8 quarters.
  • Bridgefront Capital's Labcorp position peaked at $1.02M in Q1 2024.
  • 1,024 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Bridgefront Capital's 13F filing for Q4 2025, filed 13 Feb 2026.